摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-Methoxyphenyl)-6,7-dimethyl-4-oxochromene-8-carboxylic acid | 129696-95-3

中文名称
——
中文别名
——
英文名称
2-(4-Methoxyphenyl)-6,7-dimethyl-4-oxochromene-8-carboxylic acid
英文别名
——
2-(4-Methoxyphenyl)-6,7-dimethyl-4-oxochromene-8-carboxylic acid化学式
CAS
129696-95-3
化学式
C19H16O5
mdl
——
分子量
324.333
InChiKey
GMXSJYMZSFKIPF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    72.8
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Cutler, Stephen J.; El-Kabbani, Fiesal M.; Keane, Charlene, Heterocycles, 1990, vol. 31, # 4, p. 651 - 661
    作者:Cutler, Stephen J.、El-Kabbani, Fiesal M.、Keane, Charlene、Fisher-Shore, Sherri L.、Blanton, C. DeWitt
    DOI:——
    日期:——
  • CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET
    申请人:Centre National de la Recherche Scientifique
    公开号:EP3436601A1
    公开(公告)日:2019-02-06
  • [EN] CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET<br/>[FR] NIVEAU D'EXPRESSION DE LA CYTIDINE DÉSAMINASE DANS UN CANCER EN TANT QUE NOUVELLE CIBLE THÉRAPEUTIQUE
    申请人:CENTRE NAT RECH SCIENT
    公开号:WO2017167989A1
    公开(公告)日:2017-10-05
    The present invention provides an in vitro method for selecting a patient affected with a tumor for a treatment with an antitumor compound, wherein the method comprises a step of measuring the expression level of CDA (Cytidine Deaminase) in a cancer sample from said patient. When the CDA expression level of a cancer sample is lower than the reference expression level, it is indicative that the patient is suitable for a treatment with an antitumor compound selected from the group consisting of the compounds of table 4, in particular aminoflavone. Alternatively, when the CDA expression level of a cancer sample is higher than the reference expression level, it is indicative that the patient is suitable for a treatment with an antitumor compound selected from the group consisting of the compounds of table 3, in particular dasatinib.
  • Synthesis of flavone-8-carboxylic acid analogues as potential antitumor agents
    作者:SJ Cutler、FM El-Kabbani、C Keane、SL Fisher-Shore、FL McCabe、RK Johnson、C De Witt Blanton
    DOI:10.1016/0223-5234(93)90127-z
    日期:1993.1
    Furan o-aminonitriles may be utilized as precursors in the synthesis of flavone-8-carboxylic acids. Some results from in vivo evaluation against P388 leukemia, colon carcinoma 38, and B16 melanoma models suggest that selected examples of the acids are potentially as effective as the antitumor compound, flavone acetic acid. The flavone-8-carboxylic acids did not exhibit significant activity against an in vitro HIV screen or an in vitro antitumor screen consisting of a cell panel of 60 lines.
  • Cell death triggered by synthetic flavonoids in human leukemia cells is amplified by the inhibition of extracellular signal-regulated kinase signaling
    作者:Sara Rubio、Francisco León、José Quintana、Stephen Cutler、Francisco Estévez
    DOI:10.1016/j.ejmech.2012.07.028
    日期:2012.9
    A new class of methyl esters of flavonoids, with different substituents on the B ring were synthesized and evaluated for their antiproliferative activity against the human leukemia cell line HL-60. The presence of either a methyl group (1f) or a chlorine atom (1o) at position 2' of the B ring played an important role in affecting antiproliferative activity. The cytotoxic effects of these compounds were accompanied by the concentration- and time-dependent appearance of DNA- and nuclear-fragmentation, increase in the percentage of sub-G(1) cells, and processing of multiple caspases and poly(ADP-ribose)polymerase cleavage. Pretreatment of cells with the specific mitogen-activated extracellular kinases (MEK) 1/2 inhibitor PD98059, together with if and 1o, resulted in an important enhancement of cell death, which might have clinical implications for the use of both compounds in combination with MEK 1/2 inhibitors as potential therapeutic agents. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多